Skip to main content
. Author manuscript; available in PMC: 2020 Mar 9.
Published in final edited form as: J Matern Fetal Neonatal Med. 2008 Jan;21(1):25–40. doi: 10.1080/14767050701832833

Figure 2.

Figure 2.

The mean plasma sVEGFR-1 concentrations of normal pregnant women, patients with SGA, and those with preeclampsia. Patients with preeclampsia (mean ± SD: 7,958 ± 9,170 pg/mL) and those with SGA (mean ± SD: 3,603 ± 6,740 pg/mL) had a higher mean plasma concentrations of sVEGFR-1 than normal pregnant women (mean ± SD: 1,445 ± 865 pg/mL; p < 0.001 for both). However, patients with preeclampsia had a higher mean plasma sVEGFR-1 concentration than those with SGA (p < 0.001). The comparisons were performed after logarithmic transformation (log sVEGFR-1 + 1). The statistical test used was ANOVA with Bonferroni correction for multiple comparisons. The vertical axis in the figure is in the logarithmic scale. *p < 0.05.